Luciferin liposomes for enhanced in vivo bioluminescence.
Park
Kinam
K
Purdue University, Departments of Biomedical Engineering and Pharmaceutics, West Lafayette, Indiana, USA. kpark@purdue.edu
D000818:Animals; D052160:Benzothiazoles / Q000008:administration & dosage* / Q000737:chemistry / Q000493:pharmacokinetics; D045744:Cell Line, Tumor; D002626:Chemistry, Pharmaceutical; D003692:Delayed-Action Preparations; D004339:Drug Compounding; D016503:Drug Delivery Systems; D005260:Female; D008081:Liposomes; D008156:Luciferases / Q000235:genetics / Q000378:metabolism; D049449:Luminescence; D049408:Luminescent Agents / Q000008:administration & dosage* / Q000737:chemistry / Q000493:pharmacokinetics; D008325:Mammary Neoplasms, Experimental / Q000201:enzymology / Q000235:genetics / Q000473:pathology*; D051379:Mice; D008822:Mice, Transgenic; D014162:Transfection
D052160:Benzothiazoles; C532924:D-luciferin; D003692:Delayed-Action Preparations; D008081:Liposomes; D049408:Luminescent Agents; D008156:Luciferases